Display options
Cite
Kumar D, Srivastava S, Tevatia MS, et al. Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres. Med J Armed Forces India. 2020;77(2):200-204doi: 10.1016/j.mjafi.2020.08.015.
Kumar, D., Srivastava, S., Tevatia, M. S., Kaur, K., Sood, A., Manrai, M., & Mukerjee, R. (2021). Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres. Medical journal, Armed Forces India, 77(2), 200-204. https://doi.org/10.1016/j.mjafi.2020.08.015
Kumar, Dharmendra, et al. "Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres." Medical journal, Armed Forces India vol. 77,2 (2021): 200-204. doi: https://doi.org/10.1016/j.mjafi.2020.08.015
Kumar D, Srivastava S, Tevatia MS, Kaur K, Sood A, Manrai M, Mukerjee R. Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres. Med J Armed Forces India. 2021 Apr;77(2):200-204. doi: 10.1016/j.mjafi.2020.08.015. Epub 2020 Nov 06. PMID: 33867638; PMCID: PMC8042511.
Copy Download .nbib Format: NLM
Share it on

Med J Armed Forces India. 2021 Apr;77(2):200-204. doi: 10.1016/j.mjafi.2020.08.015. Epub 2020 Nov 06.

Hepatitis B vaccination in Indian children: Seroprotection and age-related change in antibody titres.

Medical journal, Armed Forces India

Dharmendra Kumar, Sharad Srivastava, M S Tevatia, Kanwaljit Kaur, Amit Sood, Manish Manrai, Reema Mukerjee

Affiliations

  1. Senior Advisor (Medicine) & Gastroenterologist, Medical Division, Command Hospital (SC), Pune, India.
  2. Consultant (Pathology), Command Hospital (SC), Pune, India.
  3. Classified Specialist (Pathology), Base Hospital Barrackpore, Kolkata, India.
  4. Classified Specialist (Pediatrics), Command Hospital (WC), Chandimandir, India.
  5. Associate Professor, Dept of Internal Medicine, Armed Forces Medical College, Pune, India.
  6. Professor, Dept of Community Medicine, Armed Forces Medical College, Pune, India.

PMID: 33867638 PMCID: PMC8042511 DOI: 10.1016/j.mjafi.2020.08.015

Abstract

BACKGROUND: Childhood immunization against hepatitis B is one of the most effective strategies for reducing the global burden of chronic hepatitis B infection and its sequelae. There are limited data from India on both the anti-Hep B antibody titres in children after vaccination and the age-related decline in the titres. This study was planned to estimate the proportion of children in the age group of 1-10 years who develop protective levels of anti-hepatitis B antibodies after childhood vaccination and to examine the change in antibody titres with age in these children.

METHODS: A hospital-based cross-sectional study was carried out in children admitted to the hospital for various ailments. Basic demographic data, vaccination history and HBsAg status of the mother were recorded. All the enrolled children were evaluated for HBsAg and anti hepatitis B surface antibody (anti-HBS) titres. Institutional ethical clearance was obtained, and informed consent from the parents of the children was taken before drawing samples.

RESULTS: We found that 68.86% Confidence Interval ((CI): 59.8-76.8%) of the children showed protective antibody titres after vaccination, while 31.14% (CI: 23.1-40.2%) of the children had titres less than 10 IU/L. Although 100% of children in the age group from birth to three years had titres more than 10 IU/L, this percentage showed a decline across the age groups, and 60% of children aged 9-10 years had titres less than 10 IU/L.

CONCLUSION: Childhood vaccination against hepatitis B is effective in 68% children, and the antibody levels showed a steady decline with increasing age.

© 2020 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Keywords: Anti-Hbs titres; Childhood vaccination; Hepatitis B; Immunization; Protective anti-Hbs antibody

Conflict of interest statement

All authors have none to declare.

References

  1. Indian J Pediatr. 2018 Jul;85(7):510-516 - PubMed
  2. Mem Inst Oswaldo Cruz. 2012 Dec;107(8):1060-3 - PubMed
  3. J Viral Hepat. 2018 Apr;25(4):373-380 - PubMed
  4. Vaccine. 2014 Feb 7;32(7):852-6 - PubMed
  5. Hum Vaccin Immunother. 2015;11(7):1717-24 - PubMed
  6. Indian Pediatr. 2014 Nov;51(11):875-9 - PubMed
  7. Clin Infect Dis. 2011 Jul 1;53(1):68-75 - PubMed
  8. Hum Vaccin Immunother. 2017 Apr 3;13(4):918-920 - PubMed
  9. Viral Immunol. 2016 Jan-Feb;29(1):40-8 - PubMed
  10. Indian Pediatr. 2007 Sep;44(9):663-74 - PubMed
  11. Hepat Res Treat. 2017;2017:2131627 - PubMed
  12. BMC Pediatr. 2017 Jul 14;17(1):164 - PubMed
  13. J Clin Transl Hepatol. 2017 Sep 28;5(3):277-296 - PubMed
  14. J Clin Exp Hepatol. 2014 Dec;4(4):312-9 - PubMed
  15. Pediatr Infect Dis J. 2004 Jul;23(7):650-5 - PubMed
  16. Vaccine. 2013 Jan 7;31(3):448-51 - PubMed
  17. World J Pediatr. 2011 Nov;7(4):358-60 - PubMed
  18. BMC Public Health. 2019 Sep 12;19(1):1263 - PubMed
  19. Hum Vaccin Immunother. 2016 May 3;12(5):1172-6 - PubMed
  20. Sci Rep. 2018 Aug 22;8(1):12550 - PubMed
  21. Lancet. 2005 Oct 15-21;366(9494):1379-84 - PubMed
  22. Indian J Public Health. 2013 Jan-Mar;57(1):8-14 - PubMed
  23. Hum Vaccin. 2011 Dec;7(12):1387-8 - PubMed
  24. J Prev Med Hyg. 2014 Mar;55(1):1-3 - PubMed

Publication Types